BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initiating Cells with Differential Regulation of Relevant Genes Leading to Extended Survival in a NRAS/BCL-2 Mouse Model of High Risk-Myelodysplastic Syndrome.
Int J Mol Sci
; 22(19)2021 Sep 30.
Article
in En
| MEDLINE
| ID: mdl-34638998
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Stem Cells
/
Sulfonamides
/
Biphenyl Compounds
/
Myelodysplastic Syndromes
/
Signal Transduction
/
Gene Expression Regulation
/
Proto-Oncogene Proteins c-bcl-2
/
Monomeric GTP-Binding Proteins
/
Nitrophenols
Type of study:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Animals
Language:
En
Journal:
Int J Mol Sci
Year:
2021
Document type:
Article
Affiliation country:
France
Country of publication:
Switzerland